Nov 25, 2025 · Denosumab is a human monoclonal antibody that works by inhibiting RANKL (receptor activator of nuclear factor kappa-B ligand), a protein essential for osteoclasts' formation, function, …

Denosumab inhibits this maturation of osteoclasts by binding to and inhibiting RANKL. Denosumab mimics the natural action of osteoprotegerin, an endogenous RANKL inhibitor, that presents with …

Dec 1, 2025 · Denosumab injection is used to treat osteoporosis (thinning of the bones) in women who have an increased risk for fractures after menopause, and osteoporosis in men. It is given when …

Prolia® injection is a brand of denosumab, which treats osteoporosis. Osteoporosis is a condition that weakens your bones, making them more susceptible to fractures.

Denosumab, a bone anti-resorptive medication, treats osteoporosis and various bone-related disorders.

Apr 29, 2025 · Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear factor kappa-B ligand (RANKL), an osteoclast differentiating factor. It inhibits osteoclast formation, …

Jul 3, 2024 · What is denosumab used for? Denosumab (Prolia, Jubbonti, Stoboclo) is commonly used to treat osteoporosis, a condition in which the bones are thinner, weaker, and more prone to …

DENOSUMAB (den oh SUE mab) prevents weakened bones caused by cancer. It may also be used to treat noncancerous bone tumors that cannot be removed by surgery. It can also be used to treat high …

Denosumab (Prolia) is a biologic medication used to prevent fragile bones, also known as osteoporosis, and bone fractures. See how to take it and side effects.

This page contains brief information about denosumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.